# Somnigroup International Inc.: financial statements, quarterly

SGI · NYSE · CIK 1206264 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sgi.md) · [Financials](/companies/sgi/financials.md) · [Filings](/companies/sgi/filings.md) · [Insiders](/companies/sgi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sgi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,277](/filings/0001206264-24-000168.md) | [1,171 d](/filings/0001206264-26-000015.md) | [1,189](/filings/0001206264-25-000116.md) | [1,234](/filings/0001206264-25-000168.md) | [1,300](/filings/0001206264-25-000194.md) | [1,208 d](/filings/0001206264-26-000015.md) | [1,605](/filings/0001206264-26-000067.md) | [1,881](/filings/0001206264-26-000113.md) | [2,123](/filings/0001206264-25-000194.md) | [1,868 d](/filings/0001206264-26-000015.md) | [1,802](/filings/0001206264-26-000067.md) | [1,824](/filings/0001206264-26-000113.md) |
| Cost of revenue | $m | [703](/filings/0001206264-24-000168.md) | [800 d](/filings/0001206264-26-000015.md) | [715](/filings/0001206264-25-000116.md) | [716](/filings/0001206264-25-000168.md) | [749](/filings/0001206264-25-000194.md) | [723 d](/filings/0001206264-26-000015.md) | [1,024](/filings/0001206264-26-000067.md) | [1,054](/filings/0001206264-26-000113.md) | [1,170](/filings/0001206264-25-000194.md) | [1,046 d](/filings/0001206264-26-000015.md) | [1,025](/filings/0001206264-26-000067.md) | [1,006](/filings/0001206264-26-000113.md) |
| Gross profit | $m | [574](/filings/0001206264-24-000168.md) | [370 d](/filings/0001206264-26-000015.md) | [474](/filings/0001206264-25-000116.md) | [518](/filings/0001206264-25-000168.md) | [552](/filings/0001206264-25-000194.md) | [485 d](/filings/0001206264-26-000015.md) | [581](/filings/0001206264-26-000067.md) | [827](/filings/0001206264-26-000113.md) | [953](/filings/0001206264-25-000194.md) | [823 d](/filings/0001206264-26-000015.md) | [777](/filings/0001206264-26-000067.md) | [817](/filings/0001206264-26-000113.md) |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [183](/filings/0001206264-24-000168.md) | [122 d](/filings/0001206264-26-000015.md) | [132](/filings/0001206264-25-000116.md) | [173](/filings/0001206264-25-000168.md) | [202](/filings/0001206264-25-000194.md) | [128 d](/filings/0001206264-26-000015.md) | [13.2](/filings/0001206264-26-000067.md) | [180](/filings/0001206264-26-000113.md) | [315](/filings/0001206264-25-000194.md) | [247 d](/filings/0001206264-26-000015.md) | [187](/filings/0001206264-26-000067.md) | [202](/filings/0001206264-26-000113.md) |
| Interest expense | $m | [32.6](/filings/0001206264-23-000208.md) | [30.9 d](/filings/0001206264-24-000050.md) | [34.3](/filings/0001206264-24-000096.md) | [33.4](/filings/0001206264-25-000168.md) | [30.8](/filings/0001206264-25-000194.md) | [36.3 d](/filings/0001206264-26-000015.md) | [61.3](/filings/0001206264-26-000067.md) | [72.5](/filings/0001206264-26-000113.md) | [69.9](/filings/0001206264-25-000194.md) | [64.2 d](/filings/0001206264-26-000015.md) | [60.0](/filings/0001206264-26-000067.md) | [59.0](/filings/0001206264-26-000113.md) |
| Income tax | $m | [36.8](/filings/0001206264-24-000168.md) | [(4.8)](/filings/0001206264-25-000058.md) | [20.7](/filings/0001206264-25-000116.md) | [34.0](/filings/0001206264-25-000168.md) | [40.8](/filings/0001206264-25-000194.md) | [23.1 d](/filings/0001206264-26-000015.md) | [(16.5)](/filings/0001206264-26-000067.md) | [3.2](/filings/0001206264-26-000113.md) | [56.2](/filings/0001206264-25-000194.md) | [52.8 d](/filings/0001206264-26-000015.md) | [33.4](/filings/0001206264-26-000067.md) | [37.2](/filings/0001206264-26-000113.md) |
| Net income | $m | [113](/filings/0001206264-24-000168.md) | [77.1 d](/filings/0001206264-26-000015.md) | [76.3](/filings/0001206264-25-000116.md) | [106](/filings/0001206264-25-000168.md) | [130](/filings/0001206264-25-000194.md) | [71.9 d](/filings/0001206264-26-000015.md) | [(33.1)](/filings/0001206264-26-000067.md) | [99.0](/filings/0001206264-26-000113.md) | [177](/filings/0001206264-25-000194.md) | [141 d](/filings/0001206264-26-000015.md) | [104](/filings/0001206264-26-000067.md) | [111](/filings/0001206264-26-000113.md) |
| Diluted EPS | $ per share | [0.64](/filings/0001206264-24-000168.md) | not reported | [0.43](/filings/0001206264-25-000116.md) | [0.60](/filings/0001206264-25-000168.md) | [0.73](/filings/0001206264-25-000194.md) | not reported | [(0.17)](/filings/0001206264-26-000067.md) | [0.47](/filings/0001206264-26-000113.md) | [0.83](/filings/0001206264-25-000194.md) | not reported | [0.49](/filings/0001206264-26-000067.md) | [0.52](/filings/0001206264-26-000113.md) |
| Basic EPS | $ per share | [0.66](/filings/0001206264-24-000168.md) | not reported | [0.44](/filings/0001206264-25-000116.md) | [0.61](/filings/0001206264-25-000168.md) | [0.75](/filings/0001206264-25-000194.md) | not reported | [(0.17)](/filings/0001206264-26-000067.md) | [0.47](/filings/0001206264-26-000113.md) | [0.85](/filings/0001206264-25-000194.md) | not reported | [0.50](/filings/0001206264-26-000067.md) | [0.53](/filings/0001206264-26-000113.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $bn | [1.2](/filings/0001206264-23-000208.md) | [1.1](/filings/0001206264-25-000058.md) | [1.2](/filings/0001206264-24-000096.md) | [1.2](/filings/0001206264-24-000135.md) | [1.2](/filings/0001206264-24-000168.md) | [1.1](/filings/0001206264-26-000015.md) | [1.4](/filings/0001206264-25-000116.md) | [1.4](/filings/0001206264-25-000168.md) | [1.3](/filings/0001206264-25-000194.md) | [1.3](/filings/0001206264-26-000113.md) | [1.2](/filings/0001206264-26-000067.md) | [1.3](/filings/0001206264-26-000113.md) |
| Total assets | $bn | [4.5](/filings/0001206264-23-000208.md) | [4.6](/filings/0001206264-25-000058.md) | [4.6](/filings/0001206264-24-000096.md) | [4.6](/filings/0001206264-24-000135.md) | [4.6](/filings/0001206264-24-000168.md) | [6.0](/filings/0001206264-26-000015.md) | [11.3](/filings/0001206264-25-000116.md) | [11.4](/filings/0001206264-25-000168.md) | [11.4](/filings/0001206264-25-000194.md) | [11.6](/filings/0001206264-26-000113.md) | [11.5](/filings/0001206264-26-000067.md) | [11.6](/filings/0001206264-26-000113.md) |
| Current liabilities | $bn | [1.1](/filings/0001206264-23-000208.md) | [0.9](/filings/0001206264-25-000058.md) | [1.0](/filings/0001206264-24-000096.md) | [1.0](/filings/0001206264-24-000135.md) | [1.0](/filings/0001206264-24-000168.md) | [1.0](/filings/0001206264-26-000015.md) | [1.7](/filings/0001206264-25-000116.md) | [1.7](/filings/0001206264-25-000168.md) | [1.7](/filings/0001206264-25-000194.md) | [1.6](/filings/0001206264-26-000113.md) | [1.6](/filings/0001206264-26-000067.md) | [1.7](/filings/0001206264-26-000113.md) |
| Total liabilities | $bn | [4.3](/filings/0001206264-23-000208.md) | [4.2](/filings/0001206264-25-000058.md) | [4.3](/filings/0001206264-24-000096.md) | [4.2](/filings/0001206264-24-000135.md) | [4.0](/filings/0001206264-24-000168.md) | [5.4](/filings/0001206264-26-000015.md) | [8.6](/filings/0001206264-25-000116.md) | [8.5](/filings/0001206264-25-000168.md) | [8.4](/filings/0001206264-25-000194.md) | [8.5](/filings/0001206264-26-000113.md) | [8.4](/filings/0001206264-26-000067.md) | [8.4](/filings/0001206264-26-000113.md) |
| Long-term debt | $bn | not reported | [2.5](/filings/0001206264-24-000050.md) | not reported | not reported | not reported | [3.8](/filings/0001206264-25-000058.md) | not reported | [4.9](/filings/0001206264-25-000168.md) | [4.6](/filings/0001206264-25-000194.md) | [4.6](/filings/0001206264-26-000015.md) | not reported | not reported |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [0.2](/filings/0001206264-24-000168.md) | [0.3](/filings/0001206264-26-000015.md) | [0.3](/filings/0001206264-25-000168.md) | [0.4](/filings/0001206264-25-000194.md) | [0.6](/filings/0001206264-25-000194.md) | [0.6](/filings/0001206264-26-000113.md) | [2.7](/filings/0001206264-26-000113.md) | [2.8](/filings/0001206264-26-000113.md) | [3.0](/filings/0001206264-25-000194.md) | [3.1](/filings/0001206264-26-000113.md) | [3.1](/filings/0001206264-26-000113.md) | [3.2](/filings/0001206264-26-000113.md) |

- Cash and equivalents: not reported
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [229 d](/filings/0001206264-24-000168.md) | [91.1 d](/filings/0001206264-26-000015.md) | [130](/filings/0001206264-25-000116.md) | [151 d](/filings/0001206264-25-000168.md) | [257 d](/filings/0001206264-25-000194.md) | [129 d](/filings/0001206264-26-000015.md) | [106](/filings/0001206264-26-000067.md) | [186 d](/filings/0001206264-26-000113.md) | [408 d](/filings/0001206264-25-000194.md) | [99.4 d](/filings/0001206264-26-000015.md) | [247](/filings/0001206264-26-000067.md) | [236 d](/filings/0001206264-26-000113.md) |
| Capital expenditure | $m | [40.6 d](/filings/0001206264-24-000168.md) | [32.1 d](/filings/0001206264-26-000015.md) | [31.5](/filings/0001206264-25-000116.md) | [28.5 d](/filings/0001206264-25-000168.md) | [16.4 d](/filings/0001206264-25-000194.md) | [20.9 d](/filings/0001206264-26-000015.md) | [24.0](/filings/0001206264-26-000067.md) | [36.7 d](/filings/0001206264-26-000113.md) | [47.9 d](/filings/0001206264-25-000194.md) | [58.3 d](/filings/0001206264-26-000015.md) | [60.5](/filings/0001206264-26-000067.md) | [54.7 d](/filings/0001206264-26-000113.md) |
| Dividends paid | $m | [19.0 d](/filings/0001206264-24-000168.md) | [18.9 d](/filings/0001206264-26-000015.md) | [24.9](/filings/0001206264-25-000116.md) | [22.6 d](/filings/0001206264-25-000168.md) | [22.6 d](/filings/0001206264-25-000194.md) | [22.6 d](/filings/0001206264-26-000015.md) | [32.9](/filings/0001206264-26-000067.md) | [31.5 d](/filings/0001206264-26-000113.md) | [31.5 d](/filings/0001206264-25-000194.md) | [31.5 d](/filings/0001206264-26-000015.md) | [36.7](/filings/0001206264-26-000067.md) | [35.8 d](/filings/0001206264-26-000113.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [177](/filings/0001206264-23-000208.md) | [177](/filings/0001206264-24-000096.md) | [177](/filings/0001206264-24-000135.md) | [178](/filings/0001206264-24-000168.md) | [178](/filings/0001206264-25-000116.md) | [178](/filings/0001206264-25-000168.md) | [178](/filings/0001206264-25-000194.md) | [199](/filings/0001206264-26-000067.md) | [212](/filings/0001206264-26-000113.md) | [213](/filings/0001206264-25-000194.md) | [213](/filings/0001206264-26-000067.md) | [213](/filings/0001206264-26-000113.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 210,365,491 at 2026-08-04, from the cover of the [10-Q filed 2026-08-07](/filings/0001206264-26-000113.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.